Optogenetic neuromodulation with gamma oscillation as a new strategy for Alzheimer disease: a narrative review
Open Access
- 14 February 2022
- journal article
- review article
- Published by Yeungnam University College of Medicine in Journal of Yeungnam Medical Science
- Vol. 39 (4), 269-277
- https://doi.org/10.12701/jyms.2021.01683
Abstract
The amyloid hypothesis has been considered a major explanation of the pathogenesis of Alzheimer disease. However, failure of phase III clinical trials with anti-amyloid-beta monoclonal antibodies reveals the need for other therapeutic approaches to treat Alzheimer disease. Compared to its relatively short history, optogenetics has developed considerably. The expression of microbial opsins in cells using genetic engineering allows specific control of cell signals or molecules. The application of optogenetics to Alzheimer disease research or clinical approaches is increasing. When applied with gamma entrainment, optogenetic neuromodulation can improve Alzheimer disease symptoms. Although safety problems exist with optogenetics such as the use of viral vectors, this technique has great potential for use in Alzheimer disease. In this paper, we review the historical applications of optogenetic neuromodulation with gamma entrainment to investigate the mechanisms involved in Alzheimer disease and potential therapeutic strategies.Keywords
Funding Information
- Jeju National University
This publication has 99 references indexed in Scilit:
- Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-βNature Neuroscience, 2013
- Hilar GABAergic Interneuron Activity Controls Spatial Learning and Memory RetrievalPLOS ONE, 2012
- Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain α4 and β2 subunitsNeuropharmacology, 2011
- Cholinergic Interneurons Control Local Circuit Activity and Cocaine ConditioningScience, 2010
- Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitryNature, 2010
- Driving fast-spiking cells induces gamma rhythm and controls sensory responsesNature, 2009
- eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applicationsBrain Cell Biology, 2008
- Increased EEG gamma band activity in Alzheimer’s disease and mild cognitive impairmentJournal of Neural Transmission, 2008
- In Vivo Light-Induced Activation of Neural Circuitry in Transgenic Mice Expressing Channelrhodopsin-2Neuron, 2007
- Channelrhodopsin-2, a directly light-gated cation-selective membrane channelProceedings of the National Academy of Sciences of the United States of America, 2003